Promising factors are fuelling the Indian API market to grow robustly by around 18% during 2012-2015, says RNCOS.
(prHWY.com) July 27, 2012 - NOIDA, India -- According to a new research report by RNCOS entitled, "Global API Market Analysis", India is one of the most promising markets for the API industry. Several factors, such as cheap labor, affordable resources, lesser regulatory stringency and technically soundness are driving growth in its market. Outsourcing plays the most important role for India's API industry and this is reflected by the fact that the country has the biggest number of USFDA-approved plants outside the US. Amongst the key molecules produced in India, Anti-retroviral (ARVs), Anti-tubercular & Anti-malarial API products form the prominent categories. The Indian API market is slated to grow at a CAGR of around 18% from 2012-2015.
The global API industry is expected to grow primarily due to the incessant growth in the pharma industry. The rising number of patent expirations causing generics to boom, rapid drug discovery & development, reduction in manufacturing costs and greater penetration of contract manufacturing are primarily fuelling growth of APIs globally. The global API market consists primarily of the captive market. While most of the APIs produced are synthetic in nature, the biotech APIs are building up in the market and are expected to evolve more significantly. According to the latest report by RNCOS, "Global API Market Analysis", the worldwide API market size is likely to register a healthy CAGR of around 8% during 2012-2015.
The report is spread in over 80 pages provides an understanding of the API market globally and its current state. The key industry drivers have been covered in detail along with the current and future market projections for 012-2015. The major segments and sub-segments of the API industry have been covered along with the description of the API industry in the most promising geographies of India, China, Italy and Taiwan. The report also analyzes the opportunity assessment for companies in the global APIs market in terms of therapeutic segments and countries' comparative index. An analysis of the emerging areas, competitive landscape and regulatory stringency further provides a holistic understanding of the global API market.
For FREE SAMPLE of this report visit:
http://www.rncos.com/Report/IM320.htm
Some of our Related Reports are:
- Global Telemedicine Market Analysis (
http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (
http://www.rncos.com/Report/IM305.htm)
- Global Regenerative Medicine Market (
http://www.rncos.com/Report/IM363.htm)
- Emerging Pharmaceutical Markets Globally(http://www.rncos.com/Report/IM081.htm)
- Booming Clinical Trials Market in India (
http://www.rncos.com/Report/IM564.htm)
Check Related REPORTS on:
http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
###